Risk Prediction Model for Postpartum Hemorrhage
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to make childbirth safer by using a new computer model to predict postpartum hemorrhage (PPH), which is heavy bleeding after delivery. The study will compare the Novel PPH Risk Prediction Model with the current method to determine if it better assists doctors in preventing PPH. The new model updates automatically with 21 factors during labor, providing doctors with timely advice. Women giving birth at Vanderbilt University Medical Center, either vaginally or via cesarean, are eligible to participate. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could enhance childbirth safety for future mothers.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What prior data suggests that this risk prediction model is safe for use in childbirth?
Research has shown that a new tool can help predict heavy bleeding after childbirth, known as postpartum hemorrhage (PPH). This tool uses advanced computer methods to identify potential risks. Studies have demonstrated its ability to successfully predict PPH by constantly updating with new information during labor.
This tool does not involve any medication or physical procedures. Instead, it provides healthcare providers with helpful advice based on calculated risks, minimizing safety concerns for patients. The main goal is to assist doctors and nurses in making better decisions for safer deliveries.
Designed to improve care during childbirth, the tool offers real-time insights. While still under testing, early findings suggest it could better manage risks without introducing new risks to the mother or baby.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to improve how we predict the risk of postpartum hemorrhage (PPH), a serious complication after childbirth. Unlike standard care, which uses a basic category-based risk assessment tool, the novel PPH risk prediction model offers a more precise and personalized approach by integrating recent advancements in data analysis. This new model could help healthcare providers identify high-risk patients more accurately, leading to better preventative care and potentially reducing the incidence of PPH.
What evidence suggests that this novel PPH risk prediction model is effective for improving perinatal outcomes?
This trial will compare a novel postpartum hemorrhage (PPH) risk prediction model with standard care. Studies have shown that the new model can identify over 80% of severe cases. It uses advanced computer techniques to analyze 21 different factors that change during labor. The model updates instantly and alerts doctors and nurses, enabling quicker action. Although it identifies most severe cases, it may also alert for some women who don't need extra care. Overall, the model aims to make childbirth safer by better predicting and managing bleeding risks.34678
Who Is on the Research Team?
Holly Ende, MD
Principal Investigator
Vanderbilt University Medical Center
Are You a Good Fit for This Trial?
This trial is for pregnant individuals at risk of postpartum hemorrhage (PPH). Participants should be giving birth where the study is being conducted. There are no specific inclusion or exclusion criteria provided, but typically participants would need to be of childbearing age and not have conditions that could interfere with the study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are assigned to either the standard care arm or the novel PPH risk prediction model arm. The intervention arm includes additional risk prediction and Best Practice Advisory (BPA) for elevated risk cases.
Postpartum Monitoring
Participants are monitored for postpartum outcomes, including morbidity and mortality, up to 30 days postpartum.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including postpartum hospital discharge outcomes.
What Are the Treatments Tested in This Trial?
Interventions
- Novel PPH Risk Prediction Model
Find a Clinic Near You
Who Is Running the Clinical Trial?
Holly Ende
Lead Sponsor
Vanderbilt University Medical Center
Collaborator